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Prevalence and Clinical Impact of
tent Fractures After Femoropopliteal Stenting
ierk Scheinert, MD, Susanne Scheinert, MD, Jacqueline Sax, Christopher Piorkowski, MD,
ven Bräunlich, MD, Matthias Ulrich, MD, Giancarlo Biamino, MD, Andrej Schmidt, MD
eipzig, Germany
OBJECTIVES The aim of this study was to investigate the occurrence and the clinical impact of stent
fractures after femoropopliteal stenting.
BACKGROUND The development of femoral stent fractures has recently been described; however, there are no
data about the frequency and the clinical relevance.
METHODS A systematic X-ray screening for stent fractures was performed in 93 patients. In total, 121
legs treated by implantation of self-expanding nitinol stents were investigated after a mean
follow-up time of 10.7 months. The mean length of the stented segment was 15.7 cm.
RESULTS Overall, stent fractures were detected in 45 of 121 treated legs (37.2%). In a stent-based
analysis, 64 of 261 stents (24.5%) showed fractures, which were classified as minor (single
strut fracture) in 31 cases (48.4%), moderate (fracture of 1 strut) in 17 cases (26.6%), and
severe (complete separation of stent segments) in 16 cases (25.0%). Fracture rates were 13.2%
for stented length 8 cm, 42.4% for stented length 8 to 16 cm, and 52.0% for stented
length16 cm. In 21 cases (32.8%) there was a restenosis of50% diameter reduction at the
site of stent fracture. In 22 cases (34.4%) with stent fracture there was a total stent reocclusion.
According to Kaplan-Meier estimates, the primary patency rate at 12 months was signifi-
cantly lower for patients with stent fractures (41.1% vs. 84.3%, p  0.0001).
CONCLUSIONS There is a considerable risk of stent fractures after long segment femoral artery stenting,
which is associated with a higher in-stent restenosis and reocclusion rate. (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.11.026Cardiol 2005;45:312–5) © 2005 by the American College of Cardiology Foundation
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aaintaining long-term patency after recanalization of su-
erficial femoral artery (SFA) obstructions is still one of the
ost challenging aspects of endovascular therapy. Accord-
ng to several recent studies (1–3), results with self-
xpanding nitinol stents seem to be superior to the results
eported with balloon-expandable and first-generation self-
xpanding stents (4,5). This improvement may be explained
y the enhanced flexibility of the stents resulting from the
echanical characteristics of the nitinol alloy and the
egmental stent design.
Until recently, fractures of nitinol stent struts have only
een reported for single cases after stent implantation across
exion points (6). However, according to a recent study
sing systematic angiographic follow-up after long segment
emoral artery stenting with conventional and sirolimus-
luting self-expanding nitinol stents, stent fractures were
bserved in 18.2% of the cases (3).
Triggered by this observation and the unclear clinical
elevance of this phenomenon, we initiated a systematic
-ray follow-up evaluation of all patients treated in our
nstitution by implantation of self-expanding nitinol stents
nto the SFA.
ETHODS
etween April 2002 and July 2003, a total of 134 patients
ho underwent implantation of self-expanding nitinol
From the Clinical and Interventional Angiology, Heart Center-University of
eipzig, Leipzig, Germany.p
Manuscript received April 1, 2004; revised manuscript received October 17, 2004,
ccepted November 15, 2004.tents for treatment of SFA obstructions in 180 legs were
ntered into a prospective registry. In all cases, stent
mplantation was performed because of an insufficient an-
ioplasty result, defined as persistent diameter reduction
50% or dissection. The implantation regimen of the stents
as left to the discretion of the operator. Due to the extent
f the dissection, in some cases implantation of more than
wo overlapping stents or extension of the stented segment
nto the distal SFA or the first popliteal segment became
ecessary, which was discouraged in the instructions for use
f one of the devices (Luminexx, Bard). The registry
dhered to the requirements of the local ethics committee,
nd all patients gave written informed consent.
Between October 2003 and February 2004, all registry
atients returning for routine follow-up visits underwent
lain X-ray investigations of the implanted stents, irrespec-
ive of the clinical symptoms and additional findings. By
ebruary 2004, X-ray screening for stent fractures had been
erformed in 93 patients with 121 treated legs. SMART
tents (Cordis, Miami, Florida) were used in 52, SelfX
tents (Abbott Medical Devices, Beringen, Switzerland) in
4, and Luminex stents (BARD, Murray Hill, New Jersey)
n 45 limbs, respectively. Overall, 261 femoral stents with a
ean stent length of 8.6 cm were investigated. The mean
ength of the total stented segment was 15.7  5.9 cm, and
he mean number of stents per limb was 2.1  1.0. There
ere 48 legs with one, 34 legs with two, and 39 legs with
hree or more implanted femoral stents. Regarding the
natomic implantation site, 62 stents were implanted in the
roximal and 102 stents in the middle segment of the SFA.
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January 18, 2005:312–5 Stent Fractures After Femoral Stentingtotal of 97 stents were implanted in the distal third of the
FA and the first popliteal segment. The assignment of an
ndividual stent to a specific vessel segment was made by
isual estimate based on the position of the main part of the
tent.
Plain X-ray examinations of the stents were performed in
he angiography suite using at least two different angula-
ions (45° difference) and the highest available magnifi-
ation. During the same visit, all patients received a clinical
xamination including a standardized treadmill test and the
alculation of the ankle-brachial index.
Stent patency was defined as the absence of reocclusion or
estenosis of more than 50% diameter reduction. Color-
oded duplex sonography was performed in all patients to
ssess stent patency. A peak systolic velocity ratio (intraste-
otic/prestenotic) of 2.5 was considered to be indicative
or a restenosis of more than 50% diameter reduction. All
atients with symptomatic re-obstruction, as well as all
atients with evidence of stent fracture were rescheduled for
ngiography. Angiographic restenosis was defined as more
han 50% diameter reduction based on visual assessment.
tatistical analysis. Categorical variables are expressed as
umber and percentage of patients. Comparisons between
roups were performed using cross table methods with
hi-square testing between all individual groups and Bon-
erroni correction for multiple testing. Continuous variables
re presented as mean  SD, if appropriate. In case of a
on-gaussian distribution, median and range values are
iven. Stent patency rates were calculated on the basis of
olor-coded duplex sonography findings using Kaplan-
eier survival analysis. Inter-group comparisons were per-
ormed using the log-rank test.
ESULTS
-ray examinations were performed after a mean follow-up
f 10.7 months. Stent fractures were detected in 45 of 121
reated legs (37.2%). There was no difference in the time of
he X-ray examination for fractured versus non-fractured
tents (10.3 vs. 10.9 months, p  ns).
Of 261 implanted stents, 64 (24.5%) showed stent
ractures, which were classified as minor (single strut frac-
ure) in 31 cases (48.4%), moderate (fracture of 1 strut) in
7 cases (26.6%), and severe (complete separation of stent
egments) in 16 cases (25.0%) (Figs. 1 and 2). The occur-
ence of stent fractures was related to the length of the
tented segment and the number of implanted stents. The
racture rate was significantly lower for stented segments8
m with 13.2% (5 of 38 limbs) as compared with stented
egments 8 to 16 cm with 42.4% (14 of 33 limbs, p 
.005) and stented segments 16 cm with 52.0% (26 of 50
Abbreviations and Acronyms
SFA  superficial femoral arteryimbs, p  0.0001). Furthermore, fracture rates were lower
F
nor single stents: 16.7% (8 of 48) versus 41.2% (14 of 34) for
wo stents (p  0.014) and 59.0% (23 of 39) for three or
ore stents (p 0.0001). Stents with fractures were equally
istributed through the SFA with 12 stent fractures (19.4%)
n the proximal, 29 fractures in the middle (28.4%), and 23
ractures (23.7%) in the distal segment of the SFA (p ns).
gain, the time of the X-ray follow-up was similar for stents
n different anatomic locations, for single or multiple stents,
nd for different stented segment lengths.
Analyzing the performance of different stents, there was
26.9% (14 of 52) fracture rate for SMART, 29.2% (7 of
4) for SelfX, and 53.3% (24 of 45) for Luminex. No
ifferences between the groups were seen regarding the
aseline characteristics, including stented segment length
nd number of implanted stents.
igure 1. Self-expanding nitinol stent nine months after implantation
howing a severe stent fracture in the distal and a moderate stent fracture
n the proximal part of the stent. Angiographically, both lesions were
ssociated with a restenosis 50% diameter reduction.igure 2. Minor stent fracture (single strut separation). Angiographically,
o restenosis at the site of stent fracture.
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Stent Fractures After Femoral Stenting January 18, 2005:312–5The correlation of plain X-ray pictures with angiographic
ndings showed that at 21 stent fracture sites (32.8%) a
estenosis of 50% diameter reduction was detected and at
2 fracture sites (34.4%) a stent occlusion was present. In
he remaining 21 cases (32.8%), stent fractures were not
ssociated with re-obstructions (Table 1). In general, the
resence of stent fractures significantly influenced the pa-
ency of the stented segment. According to Kaplan-Meier
stimates, the primary patency rate at 12 months was 84.3%
or patients without stent fractures and only 41.1% with
tent fractures (p  0.0001) (Fig. 3).
ISCUSSION
he femoropopliteal arterial segment is known to be ex-
osed to special mechanical influences. The superficial
ourse of the artery with crossing of flexion points as well as
nteraction with the surrounding musculature, potentially
xposes the artery to relevant external forces, including
ompression, torsion, and elongation. This may have a
egative impact on vessel patency after both angioplasty and
tenting. In fact, stent compression has been identified as
ne of the principal causes of restenosis, particularly after
mplantation of balloon-expandable stents (7).
The problem of external stent compression was thought
o be overcome with the introduction of self-expanding
tents and particularly with the clinical use of the new
eneration of nitinol stents. Overall, the published results
ith this new stent generation (1–3) compared favorably
ith previous data (4,5).
So far, compression or fracture of nitinol stents in
eripheral arteries has only been reported for single cases
nd was mainly restricted to arteries crossing flexion points
uch as the popliteal or common femoral artery (6). How-
ver, the recently published observation of 18.2% stent
ractures in the Sirolimus Coated Cordis Self-expandable
tent (SIROCCO) trial (3) demonstrated impressively that
echanical stress in the femoropopliteal arteries is not
estricted to articulation sites or external compression
aused by muscle activity. In contrast, a significant amount
f internal stress seems to be transmitted to the stent
aterial as a result of the pulsatile blood flow.
This phenomenon has been described in stents positioned
ear pulsatile structures such as the heart or the proximal
reat vessels, where a fracture rate of 15% to 30% has been
Table 1. Angiographic Findings at the Site of
Stent
Fracture Stent Occlu
Mild 31 (48.4) 9 (29.0)
Moderate 17 (26.6) 6 (35.3)
Severe 16 (25.0) 7 (43.7)
Total 64 (100) 22 (34.4)
Values are n (%). *Restenosis is defined on the basis of angi
reobstruction at the site of stent fracture (occlusion and rest
significance. No significant differences were seen for mild ve
the reobstruction rate was significantly lower for mild fractureeported (8–10). Similarly, metal fatigue with nitinol strut
F
sracture has been reported for both thoracic and abdominal
ortic stent grafts (11).
Until now, the underlying mechanisms leading to stent
ractures in the SFA have not been completely understood.
imilar to the observations in the SIROCCO trial, stent
ractures in our series occurred more frequently in long
tented segments with multiple overlapping stents. This
bservation supports the hypothesis that the implantation of
ultiple overlapping stents critically increases the axial
tiffness of the stented segment. The arising question,
hether changes in the implantation regimen with avoid-
nce of stent overlap or the use of single long stents as a
ubstitute for two shorter stents would result in a reduction
f stent fractures, can not be answered from our data set.
Further, in our series, stent fractures were equally distrib-
ted throughout the SFA and there was no increased
requency of strut fractures in the distal part of the artery.
hese observations suggest that external mechanical influ-
nces from the surrounding musculature, as expected in the
dductor canal, seem to be less relevant than previously
ssumed. However, the analysis of the impact of the
natomic stent location on strut fracture is somehow limited
y the fact that assignment of stents to one or the other
egment is difficult if stents are placed across vessel segment
orders. Furthermore, the fact that in many cases multiple
verlapping stents were implanted, covering more than one
essel segment, precludes definitive conclusions for the
ndividual stent.
The most important objective of this study was to
nvestigate the clinical impact of stent fractures. In contrast
t Fracture
Restenosis* No Reobstruction
8 (25.8) 14 (45.2)
6 (35.3) 5 (29.4)
7 (43.7) 2 (12.5)
21 (32.8) 21 (32.8)
y as 50% diameter obstruction. Differences in the rate of
) for fractures of different severity were tested for statistical
oderate or moderate versus severe stent fractures. However,
f 31 (55%) versus severe fractures, 14 of 16 (88%), p 0.025.Sten
sion
ograph
enosisigure 3. Primary stent patency rates for fractured and non-fractured
tents. Squares  no stent fracture; triangles  stent fracture.
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January 18, 2005:312–5 Stent Fractures After Femoral Stentingo the observation in the SIROCCO trial, where no
orrelation between stent fractures and re-obstructions
ould be established (3), our data demonstrate that stent
ractures were associated with stent restenosis or reocclu-
ions in about two-thirds of the cases. Particularly when
tent fractures were categorized as severe, relevant re-
bstructions were observed in almost all cases. Furthermore,
he primary patency rate of the stented segment was
ignificantly lower for patients with stent fractures, demon-
trating the clinical relevance of this finding.
There are some limitations of this study that leave our
nderstanding of the mechanisms of stent fractures incom-
lete. First, this study was based on a single X-ray investi-
ation performed in every patient at different follow-up
imes. Therefore, no sequential examinations are available,
reventing the ability to follow the timing of stent fracture
evelopment. Furthermore, in this study only self-
xpanding nitinol stents with a segmental design were
tudied. Different fracture rates of the nitinol stent brands
sed in our patients have to be interpreted cautiously as the
llocation of stents was non-randomized. Moreover, the
ifferences noted in our study were detected in relatively
ong lesions treated with overlapping stents. Stenting of
horter vessel segments or the use of single stents may yield
ifferent results. Because the available investigations for
itinol stents with a spiral design were mainly focused on
horter lesions and did not incorporate a systematic X-ray
ollow-up (12), no conclusions can be drawn as to whether
spiral design provides more longitudinal in situ flexibility
eading to more favorable results in diffuse femoral disease.
inally, the question of whether a different implantation
egimen without stent overlap can contribute to a reduction
f stent fractures needs to be investigated.
In conclusion, stent fractures occur frequently after long
egment femoral artery stenting. Although mild or moder-
te fractures may be a benign condition in some patients,
evere stent fractures are associated with stent restenosis or
eocclusion in the majority of the cases. In general, theccurrence of stent fractures is associated with a reduction in
he overall patency rate.
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